MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Hirata, Hiroshi ^a   Ueno, Koji ^a   Shahryari, Varahram ^a   Deng, Guoren ^a   Tanaka, Yuichiro ^a   Tabatabai, Z Laura ^b   Hinoda, Yuji ^c   Dahiya, Rajvir ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 182 5P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; FOXF2 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MTSS1 GENE; NONHUMAN; OVERALL SURVIVAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN RNA BINDING; RECK GENE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GPI-LINKED PROTEINS; HUMANS; MALE; MICE; MICE, NUDE; MICROFILAMENT PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RNA INTERFERENCE; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873850704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055502     Document Type: Article

References (36)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Roemeling S, Roobol MJ, de Vries SH, Gosselaar C, van der Kwast, et al. (2006) Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. J Urol 175: 1332-1336.
3. Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, et al. (2006) Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 17: 199-208.
4. Shukla S, Gupta S, (2005) Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53: 18-32.
5. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, et al. (2001) Risk of prostate carcinoma death in patients with lymph nodemetastasis. Cancer 91: 66-73.
6. Trang P, Weidhaas JB, Slack FJ, (2008) MicroRNAs as potential cancer therapeutics. Oncogene 27: S52-S7.
7. Inui M, Martello G, Piccolo S, (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
8. Fabbri M, Croce CM, Calin GA, (2008) MicroRNAs. Cancer J 14: 1-6.
9. Zhang B, Pan X, Cobb GP, Anderson TA, (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
10. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, et al. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176.
11. Pang Y, Young CY, Yuan H, (2010) MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai) 42: 363-369.
12. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
13. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, et al. (2010) Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29.
14. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, et al. (2011) miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 71: 538-549.
15. Li T, Li D, Sha J, Sun P, Huang Y, (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285.
16. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, et al. (2009) miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 69: 7165-7169.
17. Zhang L, Liu T, Huang Y, Liu J, (2011) microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. Int J Mol Med 28: 381-388.
18. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, et al. (2009) Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 106: 1814-1819.
19. Guttilla IK, White BA, (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284: 23204-23216.
20. Jiang L, Mao P, Song L, Wu J, Huang J, et al. (2010) miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177: 29-38.
21. Liu Z, Liu J, Segura MF, Shao C, Lee P, et al. (2012) MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol 228: 204-215.
22. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, et al. (2011) miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem 286: 44503-44511.
23. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, et al. (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377.
24. Clark JC, Thomas DM, Choong PF, Dass CR, (2007) RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 26: 675-683.
25. Rabien A, Ergün B, Erbersdobler A, Jung K, Stephan C, (2012) RECK overexpression decreases invasive potential in prostate cancer cells. Prostate 72: 948-54.
26. Yoshida Y, Ninomiya K, Hamada H, Noda M, (2012) Involvement of the SKP2-p27(KIP1) pathway in suppression of cancer cell proliferation by RECK. Oncogene 31: 4128-4138.
27. Clark JC, Akiyama T, Thomas DM, Labrinidis A, Evdokiou A, et al. (2011) RECK in osteosarcoma: a novel role in tumour vasculature and inhibition of tumorigenesis in an orthotopic model. Cancer 117: 3517-3528.
28. Reis ST, Pontes-Junior J, Antunesnes AA, Dall'Oglio MF, Dip N, et al. (2012) miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol 12: 14.
29. Li N, Tang B, Zhu ED, Li BS, Zhuang Y, et al. (2012) Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett 586: 722-728.
30. Lee YG, Macoska JA, Korenchuk S, Pienta KJ, (2002) MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4: 291-294.
31. Mustafa N, Martin TA, Jiang WG, (2011) Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells. Exp Ther Med 2: 157-162.
32. Wang J, Li J, Shen J, Wang C, Yang L, et al. (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12: 227.
33. van der Heul-Nieuwenhuijsen L, Dits N, van Ijcken W, de Lange D, Jenster G, (2009) The FOXF2 pathway in the human prostate stroma. Prostate 69: 1538-1547.
34. Ormestad M, Astorga J, Landgren H, Wang T, Johansson BR, et al. (2006) Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 133: 833-843.
35. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, et al. (2010) Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29: 2036-2046.
36. Shi W, Gerster K, Alajez NM, Tsang J, Waldron L, et al. (2011) MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 71: 2926-2937.